Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Controlling spending demands consistent routines and clear boundaries. This guide outlines practical steps to reinforce disciplined habits daily.
15,859 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
A prominent wall street tech analyst says Micron could soar fourfold if AI infrastructure spending remains robust thr...
A transformative update could reshape Micron stock dynamics. This guide breaks down what the news might mean, how to ...
Analysts outline a path for Amazon to approach $300 in the next 12-15 months, anchored by cloud, ads, and Prime-drive...
Could Micron Technology stock reach 2000 within a year? This article breaks down the catalysts, the math, and the ris...
Record heat across Europe and North America is reframing climate planning, led by new insights from the McKinsey Glob...
Asia’s aging demographics are fueling a surge in high-end longevity clinics and wellness residencies, creating new op...
Seoul unveiled a sweeping AI infrastructure plan valued at south korea’s $576 billion, a move that investors say coul...
Markets rally as AI progress accelerates, steering investment toward compute, energy, and robotics. Analysts warn the...
Memory chips sit at the heart of AI infrastructure. As demand climbs, investors ask if will memory giants micron can ...
A Goldman Sachs economist offers reality on AI adoption timing, arguing that productivity gains from AI are likely to...
A floated plan to require annual testosterone screening for service members 30 and older could reshape military healt...